Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H10N2O6 |
Molecular Weight | 314.2497 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C1=CC=C(O)C2=NC3=C(C=O)C(O)=CC(O)=C3N=C12
InChI
InChIKey=CRANETCJDDEINO-UHFFFAOYSA-N
InChI=1S/C15H10N2O6/c1-23-15(22)6-2-3-8(19)13-11(6)16-14-10(21)4-9(20)7(5-18)12(14)17-13/h2-5,19-21H,1H3
Lomofungin, a natural product compound first isolated from the soil-dwelling Gram-positive bacteria Streptomyces lomodensis. Lomofungin has a broad antibacterial and antifungal spectrum, being active against gram-positive and gram-negative bacteria, yeasts, and other fungi. It prevents RNA synthesis by a direct interaction with the bacterial DNA-dependent ribonucleic acid (RNA) polymerase and not with the template or substrate. Lomofungin was identified as an inhibitor of botulinum neurotoxin light chain protease and as a potential therapeutic for myotonic dystrophy type 1. Lomofungin inhibited HIV-1 replication in peripheral blood mononuclear cells.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL5192 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20959871 |
6.7 µM [Ki] | ||
Target ID: CUG(exp) RNA Sources: https://www.ncbi.nlm.nih.gov/pubmed/24799433 |
|||
Target ID: CHEMBL2364672 Sources: https://www.ncbi.nlm.nih.gov/pubmed/4790624 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5803629
Lomofungin inhibited the growth of some yeasts and mycelial fungi at concentrations between 5 and 10 ug/ml. At such concentrations, there was no decrease in endogenous and exogenous oxygen consumption, and even 50 ug of antibiotic per ml caused only slight decreases. The permeation of the cell membrane was changed so that leakage of ninhydrin-positive substances was reduced, and the uptake of (14)C-labeled glucose, amino acids, uracil, and thymidine was decreased at concentrations as low as 4 ug/ml. Protein synthesis in whole cells of Saccharomyces cerevisiae was reduced 35% at 10 ug/ml.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
26786-84-5
Created by
admin on Fri Dec 15 15:16:57 GMT 2023 , Edited by admin on Fri Dec 15 15:16:57 GMT 2023
|
PRIMARY | |||
|
5351222
Created by
admin on Fri Dec 15 15:16:57 GMT 2023 , Edited by admin on Fri Dec 15 15:16:57 GMT 2023
|
PRIMARY | |||
|
106995
Created by
admin on Fri Dec 15 15:16:57 GMT 2023 , Edited by admin on Fri Dec 15 15:16:57 GMT 2023
|
PRIMARY | |||
|
DTXSID90949590
Created by
admin on Fri Dec 15 15:16:57 GMT 2023 , Edited by admin on Fri Dec 15 15:16:57 GMT 2023
|
PRIMARY | |||
|
156939
Created by
admin on Fri Dec 15 15:16:57 GMT 2023 , Edited by admin on Fri Dec 15 15:16:57 GMT 2023
|
PRIMARY | |||
|
Z6Z18X1Y4D
Created by
admin on Fri Dec 15 15:16:57 GMT 2023 , Edited by admin on Fri Dec 15 15:16:57 GMT 2023
|
PRIMARY | |||
|
C170125
Created by
admin on Fri Dec 15 15:16:57 GMT 2023 , Edited by admin on Fri Dec 15 15:16:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL1505471
Created by
admin on Fri Dec 15 15:16:57 GMT 2023 , Edited by admin on Fri Dec 15 15:16:57 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD